Arterial Inflammation and E-Cigarettes
Not Applicable
Completed
- Conditions
- Arterial Inflammation
- Registration Number
- NCT02734888
- Lead Sponsor
- University of California, Los Angeles
- Brief Summary
Arterial inflammation will be compared using PET scanning in 3 groups: 1) Non-smokers, 2) Tobacco cigarette smokers, 3) Electronic cigarette users.
- Detailed Description
Qualified participants will undergo a singe PET/CT to detect arterial inflammation.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Healthy
- Nonsmokers OR
- Daily e-cigarette user OR
- Daily tobacco cigarette smoker
Exclusion Criteria
- Cardiac disease
- Respiratory Disease
- Diabetes mellitus
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method target-to-background ratio (TBR) intraoperative TBR will be detected on the scan
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link e-cigarette use to arterial inflammation as studied in NCT02734888?
How does arterial inflammation in e-cigarette users compare to traditional smokers using PET/CT biomarkers?
Are there specific biomarkers identified in NCT02734888 for predicting vascular inflammatory responses to nicotine delivery methods?
What are the potential adverse events associated with PET/CT scanning in assessing arterial inflammation in this trial?
How do findings from NCT02734888 contribute to understanding cardiovascular risks of vaping versus smoking?
Trial Locations
- Locations (1)
UCaliforniaLA
🇺🇸Los Angeles, California, United States
UCaliforniaLA🇺🇸Los Angeles, California, United States